SCHEMBL4946889

SCHEMBL4946889

Nc1nn[nH]c2cnnc1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60386 0.68 KDM4A (0.33)
SCHEMBL218983 0.61
SCHEMBL18879050 0.56
SCHEMBL5020178 0.56 ASIC3 (0.48)
SCHEMBL3790626 0.56
SCHEMBL31192222 0.55 NOTUM (0.41)
SCHEMBL29689434 0.54
SCHEMBL13411815 0.54 POLB (0.33)
SCHEMBL14521987 0.53
SCHEMBL28785812 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218360-B1 TRIAZINE KINASE INHIBITORS AMGEN INC (US) 2008-05-28 EP disclosed
US-7074789-B2 Kinase inhibitors AMGEN INC. (US) 2006-07-11 US disclosed
US-20040116388-A1 triazine compoound inhibitors of enzymes that catalyze phosphoryl transfer and/or that bind ATP/GTP nucleotides AMGEN INC. 2004-06-17 US disclosed
EP-1218360-A1 TRIAZINE KINASE INHIBITORS Amgen Inc., (US) 2002-07-03 EP disclosed
WO-2001025220-A1 TRIAZINE KINASE INHIBITORS AMGEN INC. (US) 2001-04-12 WO disclosed